22min chapter

HealthTree Podcast for Multiple Myeloma cover image

Today's CAR T Options in Multiple Myeloma Care with Luciano Costa, MD, UAB

HealthTree Podcast for Multiple Myeloma

CHAPTER

Advancements in CAR-T Therapy for Multiple Myeloma Patients

Exploring the latest FDA-approved drugs PECMA and CAR-VICTI for heavily relapsed multiple myeloma patients, highlighting their high response rates compared to older drugs. The discussion delves into the challenges of using CAR-T therapies in clinical settings, emphasizing the complexities of patient eligibility and timing constraints. Additionally, the chapter addresses the unpredictability of therapy responses, typical side effects like cytokine release syndrome and neurotoxicity, and the management of potential neurological side effects in cancer treatment.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode